Rare diseases
Investigational molecules
Locations
Back to the Netherlands144 clinical trials in Tilburg, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
The NetherlandsA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
The NetherlandsA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
The NetherlandsA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
The NetherlandsA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
The NetherlandsStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
The NetherlandsA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
The NetherlandsStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
The NetherlandsStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
The NetherlandsStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
The NetherlandsStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for inflammatory bowel diseases, particularly evaluating new therapies for Crohn's Disease and Ulcerative Colitis. Studies include long-term safety assessments and combination therapy approaches.
Advanced clinical trials examining novel therapeutic agents and their effectiveness in treating moderate to severe digestive conditions.
Comprehensive studies addressing cardiovascular disease management, including investigations into peripheral arterial disease and innovative approaches to reducing cardiovascular events.
Trials focusing on both preventive measures and treatment strategies for various cardiovascular conditions.
Innovative research in cancer treatment, including breast cancer, colorectal cancer, and advanced therapeutic approaches for various tumor types.
Studies evaluating targeted therapies and combination treatments for various stages of cancer.
Research examining autoimmune conditions and inflammatory disorders, with particular focus on novel therapeutic approaches and long-term disease management.
Investigations into innovative treatment options for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
